Interrand Inc.

Randomize.net is an internet-based Interactive Web Response System (IWRS) developed and operated by Interrand Inc., based in Ottawa, Canada. The platform manages subject randomization and drug supply for clinical trials, and has been providing this service since 2000, with hundreds of trials completed. The system was developed under the supervision of Andrew Willan, PhD, Professor of Biostatistics at the University of Toronto and Professor Emeritus of Clinical Epidemiology and Biostatistics at McMaster University.

Randomize.net serves academic institutions, hospitals, and private sector organizations running clinical trials. Users can create a randomization application in minutes, with no cost incurred until the trial is activated. The platform is fully compliant with FDA 21 CFR Part 11.

Core Features and Capabilities

• Randomization algorithms: Supports permuted blocked stratification, minimization, and simple randomization algorithms.
• Double-blinded trial support: Includes kit management, kit replacement, and emergency unblinding functionality.
• User management: Allows creation of multiple Coordinating Center users with defined roles, including Administrator, Auditor, and Kit Administrator.
• Real-time reports: Users can view and download real-time reports at any time.
• Email notifications: Fully configurable email notification system.
• Customizable trials: Randomization applications can be configured with specific options and features to match trial requirements.
• Systems integration: A Web Service API is available to integrate randomization functionality into external applications, with full support for subject randomization and reporting.

Unlimited Usage Model

• No restrictions on trial duration, number of subjects, clinical sites, treatment arms, or stratification variables.
• All plans include unlimited support and downloadable reports.
• There is no cost until the trial is activated; the activation fee is a one-time charge due within 30 days of activation.

Pricing

• Academic/Hospital-Funded Trials: $2,500 per trial (one-time activation fee), covering unlimited trial duration, unlimited clinical sites, unlimited subjects, downloadable reports, and unlimited support.
• Private Sector-Funded Trials: $4,500 per trial (one-time activation fee), with the same unlimited inclusions as the academic tier.
• Additional costs may apply for trial customization and minimization; a custom quote can be requested by email.

Notable Users and Institutions

• Hospital for Sick Children, Toronto
• University of Virginia Health System
• Kingston General Hospital (Cardiac Surgery)
• Sunnybrook Health Sciences Centre, Women and Babies Program

Randomize.net is owned and operated by Interrand Inc., located in Ottawa, Ontario, Canada. The platform is positioned as a straightforward, validated IWRS solution for clinical trial teams seeking a configurable and cost-predictable randomization service.